Prof. Cristina Granziera

University of Basel 🇨🇭

Cristina Granziera, MD PhD is the co-CEO of the Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), a professor at the University of Basel, and a senior consultant neurologist at the University Hospital of Basel. Dr. Granziera received her MD from Padova University Medical School in Italy in 2001, followed by a PhD in Neuroscience from Lausanne University in Switzerland in 2007. In 2010, she acquired the Swiss Neurology board. She was appointed as a lecturer at the University of Lausanne in 2011 and was promoted to senior lecturer in 2014. In 2015, she joined the Massachusetts General Hospital (MGH) and Harvard Medical School as an assistant professor in Radiology and assistant in Biomedical Engineering.

Cristina is the co-president of the scientific advisory board of the Swiss MS Society, a member of the ECTRIMS steering committee (Congress Of The European Committee For Treatment And Research In Multiple Sclerosis), president of the white matter study group of ISMRM (International Society for Magnetic Resonance in Medicine), and a member of the EBRAINS (European Brain Research Infrastructures) 2.0 advisory group.

Dr. Granziera’s research focuses on investigating the pathogenesis of neuroinflammatory and cerebrovascular diseases such as multiple sclerosis, neuroHIV, migraine, and stroke. She uses state-of-the-art neuroimaging methods and is particularly interested in the combination of multiple quantitative MRI contrasts to achieve the highest sensitivity and specificity to brain tissue pathology, as well as in multi-modal approaches like MRI-PET. Her goal is to propose new models of disease impact and innovative tools to study disease evolution by using the combined information of neuroimaging data, biological and clinical markers of disease.